TOCILIZUMAB Pharmacologic Class Indexing
- Class set ID
- dca82777-ca3b-4701-8f1e-e802aba2b829
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use AVTOZMA safely and effectively. See full prescribing information for AVTOZMA. AVTOZMA ® (tocilizumab-anoh) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2025 AVTOZMA (tocilizumab-anoh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful | CELLTRION USA, Inc. | 20260123 | 4 |
| These highlights do not include all the information needed to use TOCILIZUMAB-ANOH safely and effectively. See full prescribing information for TOCILIZUMAB-ANOH. TOCILIZUMAB-ANOH injection, for intravenous or subcutaneous use Initial U.S. Approval: 2025 Tocilizumab-anoh is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful dif | CELLTRION USA, Inc. | 20260123 | 4 |
| These highlights do not include all the information needed to use TOFIDENCE safely and effectively. See full prescribing information for TOFIDENCE. TOFIDENCE™ (tocilizumab-bavi) injection, for intravenous use Initial U.S. Approval: 2023 TOFIDENCE (tocilizumab-bavi) is biosimilar 1 to ACTEMRA (tocilizumab). 1 - Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are n | Biogen MA Inc | Avista Pharma Solutions, Inc dba Cambrex | BioReliance Corporation | BioReliance Ltd. | Bio-Thera Solutions, Ltd | Biogen Inc. | Biogen U.S. Corporation | Eurofins BioPharma Product Testing Munich GmbH | Sharp Packaging Services, LLC | 20251219 | 10 |
| These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA ® (tocilizumab) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2010 | Genentech, Inc. | F. Hoffmann-La Roche AG | Genentech, Inc. (Oceanside) | Roche Diagnostics GmbH | Genentech, Inc. (Hillsboro) | 20251216 | 53 |
| These highlights do not include all the information needed to use TYENNE safely and effectively. See full prescribing information for TYENNE. TYENNE ® (tocilizumab-aazg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2024 TYENNE ® (tocilizumab-aazg) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful d | Fresenius Kabi USA, LLC | Fresenius Kabi Austria GmbH | MERCK SERONO S.p.A | 20251126 | 4 |
| These highlights do not include all the information needed to use TOFIDENCE safely and effectively. See full prescribing information for TOFIDENCE. TOFIDENCE ® (tocilizumab-bavi) injection, for intravenous use Initial U.S. Approval: 2023 TOFIDENCE (tocilizumab-bavi) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe | Organon LLC | 20250922 | 2 |
| These highlights do not include all the information needed to use TYENNE safely and effectively. See full prescribing information for TYENNE. TYENNE ® (tocilizumab-aazg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2024 TYENNE ® (tocilizumab-aazg) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful d | Fresenius Kabi USA, LLC | Fresenius Kabi Austria GmbH | MERCK SERONO S.p.A | 20250826 | 1 |
| These highlights do not include all the information needed to use TYENNE safely and effectively. See full prescribing information for TYENNE. TYENNE ® (tocilizumab-aazg) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2024 TYENNE ® (tocilizumab-aazg) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful d | Fresenius Kabi USA, LLC | Fresenius Kabi Austria GmbH | 20241230 | 2 |